High Growth Tech Stocks to Watch in September 2024 [Yahoo! Finance]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Yahoo! Finance
Top 10 High Growth Tech Companies Clinuvel Pharmaceuticals ?????? Sarepta Therapeutics ?????? Seojin SystemLtd ?????? TG Therapeutics ?????? eWeLLLtd ?????? Scandion Oncology ?????? KebNi ?????? Adveritas ?????? Travere Therapeutics ?????? UTI ?????? Here's a peek at a few of the choices from the screener. Simply Wall St Growth Rating: ?????? Overview: Gan & Lee Pharmaceuticals is a biopharmaceutical company focused on the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China, with a market cap of CN¥25.29 billion. Operations: Gan & Lee Pharmaceuticals primarily generates revenue from the development, production, and sales of insulin and related products, amounting to CN¥2.69 billion. The company's operations are concentrated in China. Gan & Lee Pharmaceuticals has demonstrated robust growth, with revenue and earnings forecast to outpace the Chinese market at 26.
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- High Growth Tech And 2 Other High Potential Stocks To Watch [Yahoo! Finance]Yahoo! Finance
- Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society CongressBusiness Wire
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $152.00 price target on the stock.MarketBeat
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.MarketBeat
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at UBS Group AG from $173.00 to $188.00. They now have a "buy" rating on the stock.MarketBeat
SRPT
Earnings
- 8/7/24 - Beat
SRPT
Sec Filings
- 9/16/24 - Form 4
- 9/16/24 - Form 3
- 9/16/24 - Form 8-K
- SRPT's page on the SEC website